Synonyms: SCE-2787
cefozopran is an approved drug (Japan)
Compound class:
Synthetic organic
Comment: Cefozopran is a fourth generation cephalosporin, belonging to the β-lactam class of antibacterial compounds. It has broad-spectrum activity and was developed by Takeda for parenteral treatment of infections caused by a range of Gram-positive and Gram-negative bacteria [1-2].
|
|
Bioactivity Comments |
Cefozopran has a broad-spectrum of activity against a range of bacteria including methicillin-susceptible Staphylococcus aureus (MSSA; MIC90 of 0.78 μg/ml), Pseudomonas aeruginosa (MIC90 of 6.25 μg/ml) and Streptococcus spp. (MIC90 of < 0.1 μg/ml) [1]. It is resistant to hydrolysis by many common β-lactamases. |